Global Endobronchial Ultrasound Biopsy

Endobronchial Ultrasound Biopsy Comprehensive Study by Type (Biopsy Forceps, Cytology Brushes, Biopsy Needles, Transbronchial Aspiration Needles, Spray Catheters, Others), Application (Infection Diagnosis, Cancer Diagnosis, Others), End User (Hospitals, Cancer Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers) Players and Region - Global Market Outlook to 2030

Endobronchial Ultrasound Biopsy Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Endobronchial Ultrasound Biopsy
Lung bronchoscopy and critical care drugs have greatly improved the advances in endoscopic techniques in recent years. Endobronchial Ultrasound (EBUS) is one such technique that has modernized the pulmonologist's ability so as to take samples (biopsy) and visualize the structure around the tracheobronchial tree. EBUS and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS TBNA) are relatively new techniques and effective methods for evaluating lung nodules and diagnosing lung infections and stages of lung cancer. In addition, endobronchial ultrasound biopsy is also used to identify other diseases such as tuberculosis and chronic pulmonary obstruction disorders that can affect the lungs and other respiratory organs. For example, breast masses and enlarged lymph nodes, among others. Since its introduction in the early 1980s, endoscopic ultrasound (EUS) has gained acceptance in the rapidly growing areas of gastroenterology and pulmonology. In endoscopic ultrasound, the doctor inserts a special bronchoscope through the patient's mouth into the windpipe, which penetrates further into the two main airways (bronchi) in the lungs. The bronchoscope is equipped with a fine aspiration needle and an ultrasound processor. An ultrasound monitor thereby shows real-time images of the blood vessels, airways, lungs, and neighboring lymph nodes. The doctor passes the needle through the bronchial walls to obtain a sample of the cells in the mediastinal lymph nodes. The biopsy samples can be examined to diagnose lung cancer and other diseases. Samples or specimens taken during the biopsy are examined using histological and cytological examinations of the respective organ. It is a minimally invasive technique used to collect tissue samples for biopsy. These techniques are widely used because they do not cause much discomfort to patients and in most cases do not require surgery.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Endobronchial Ultrasound Biopsy market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Olympus Corporation (Japan), Medtronic (Ireland), Cook Medical (United States), CONMED Corporation (United States), Medi-Globe Corporation (United States), Veran Medical Technologies (United States), Boston Scientific Corporation (United States), ACE Medical Devices Pvt. Ltd. (India), CLINODEVICE (Turkey), ENDO-FLEX GmbH (Germany) and Micro-Tech Endoscopy (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Endobronchial Ultrasound Biopsy market by Type (Biopsy Forceps, Cytology Brushes, Biopsy Needles, Transbronchial Aspiration Needles, Spray Catheters and Others), Application (Infection Diagnosis, Cancer Diagnosis and Others) and Region.



On the basis of geography, the market of Endobronchial Ultrasound Biopsy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by End User, the sub-segment i.e. Hospitals will boost the Endobronchial Ultrasound Biopsy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
The Rapidly Growing Fields of Gastroenterology and Pulmonology and Increasing Demand for Minimally Invasive Procedures

Market Growth Drivers:
Rising Geriatric Population, Increasing Prevalence of Cancer, Increasing Prevalence of Respiratory Disorders and Increasing Incidence of Diseases That Require Endoscopic Ultrasound Procedures

Challenges:
Lack Reimbursement Policies in Developing Countries

Restraints:
High Cost of Equipment

Opportunities:
A Well-Structured Healthcare System That Promotes Researches and Technological Advancements and Increase Government Initiative in Healthcare Awareness

Market Leaders and their expansionary development strategies
In October 2023, Praxis Medical announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of the EndoCore EBUS-TBNA fine needle biopsy device. Endobronchial ultrasound with transbronchial needle aspiration (EBUS-TBNA) is used for the diagnosis and staging of lung cancer. This procedure is performed by inserting a long, flexible fine needle through a bronchoscope for biopsy and pathological analysis.
In May 2021, Olympus announced today the market launch of the FDA 510(k)-cleared BF-UC190F endobronchial ultrasound (EBUS) bronchoscope, the newest addition to its robust EBUS portfolio of devices for minimally invasive lung cancer diagnosis and staging via needle biopsy.


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Endobronchial Ultrasound Biopsy, Venture Capitalists and Private Equity Firms and End-Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Biopsy Forceps
  • Cytology Brushes
  • Biopsy Needles
  • Transbronchial Aspiration Needles
  • Spray Catheters
  • Others
By Application
  • Infection Diagnosis
  • Cancer Diagnosis
  • Others
By End User
  • Hospitals
  • Cancer Specialty Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Geriatric Population
      • 3.2.2. Increasing Prevalence of Cancer
      • 3.2.3. Increasing Prevalence of Respiratory Disorders
      • 3.2.4. Increasing Incidence of Diseases That Require Endoscopic Ultrasound Procedures
    • 3.3. Market Challenges
      • 3.3.1. Lack Reimbursement Policies in Developing Countries
    • 3.4. Market Trends
      • 3.4.1. The Rapidly Growing Fields of Gastroenterology and Pulmonology
      • 3.4.2. Increasing Demand for Minimally Invasive Procedures
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Endobronchial Ultrasound Biopsy, by Type, Application, End User and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Endobronchial Ultrasound Biopsy (Value)
      • 5.2.1. Global Endobronchial Ultrasound Biopsy by: Type (Value)
        • 5.2.1.1. Biopsy Forceps
        • 5.2.1.2. Cytology Brushes
        • 5.2.1.3. Biopsy Needles
        • 5.2.1.4. Transbronchial Aspiration Needles
        • 5.2.1.5. Spray Catheters
        • 5.2.1.6. Others
      • 5.2.2. Global Endobronchial Ultrasound Biopsy by: Application (Value)
        • 5.2.2.1. Infection Diagnosis
        • 5.2.2.2. Cancer Diagnosis
        • 5.2.2.3. Others
      • 5.2.3. Global Endobronchial Ultrasound Biopsy by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Cancer Specialty Clinics
        • 5.2.3.3. Ambulatory Surgical Centers
        • 5.2.3.4. Diagnostic Centers
      • 5.2.4. Global Endobronchial Ultrasound Biopsy Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Endobronchial Ultrasound Biopsy (Price)
      • 5.3.1. Global Endobronchial Ultrasound Biopsy by: Type (Price)
  • 6. Endobronchial Ultrasound Biopsy: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Olympus Corporation (Japan)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Medtronic (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Cook Medical (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. CONMED Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Medi-Globe Corporation (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Veran Medical Technologies (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Boston Scientific Corporation (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ACE Medical Devices Pvt. Ltd. (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. CLINODEVICE (Turkey)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. ENDO-FLEX GmbH (Germany)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Micro-Tech Endoscopy (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Endobronchial Ultrasound Biopsy Sale, by Type, Application, End User and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Endobronchial Ultrasound Biopsy (Value)
      • 7.2.1. Global Endobronchial Ultrasound Biopsy by: Type (Value)
        • 7.2.1.1. Biopsy Forceps
        • 7.2.1.2. Cytology Brushes
        • 7.2.1.3. Biopsy Needles
        • 7.2.1.4. Transbronchial Aspiration Needles
        • 7.2.1.5. Spray Catheters
        • 7.2.1.6. Others
      • 7.2.2. Global Endobronchial Ultrasound Biopsy by: Application (Value)
        • 7.2.2.1. Infection Diagnosis
        • 7.2.2.2. Cancer Diagnosis
        • 7.2.2.3. Others
      • 7.2.3. Global Endobronchial Ultrasound Biopsy by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Cancer Specialty Clinics
        • 7.2.3.3. Ambulatory Surgical Centers
        • 7.2.3.4. Diagnostic Centers
      • 7.2.4. Global Endobronchial Ultrasound Biopsy Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Endobronchial Ultrasound Biopsy (Price)
      • 7.3.1. Global Endobronchial Ultrasound Biopsy by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Endobronchial Ultrasound Biopsy: by Type(USD Million)
  • Table 2. Endobronchial Ultrasound Biopsy Biopsy Forceps , by Region USD Million (2018-2023)
  • Table 3. Endobronchial Ultrasound Biopsy Cytology Brushes , by Region USD Million (2018-2023)
  • Table 4. Endobronchial Ultrasound Biopsy Biopsy Needles , by Region USD Million (2018-2023)
  • Table 5. Endobronchial Ultrasound Biopsy Transbronchial Aspiration Needles , by Region USD Million (2018-2023)
  • Table 6. Endobronchial Ultrasound Biopsy Spray Catheters , by Region USD Million (2018-2023)
  • Table 7. Endobronchial Ultrasound Biopsy Others , by Region USD Million (2018-2023)
  • Table 8. Endobronchial Ultrasound Biopsy: by Application(USD Million)
  • Table 9. Endobronchial Ultrasound Biopsy Infection Diagnosis , by Region USD Million (2018-2023)
  • Table 10. Endobronchial Ultrasound Biopsy Cancer Diagnosis , by Region USD Million (2018-2023)
  • Table 11. Endobronchial Ultrasound Biopsy Others , by Region USD Million (2018-2023)
  • Table 12. Endobronchial Ultrasound Biopsy: by End User(USD Million)
  • Table 13. Endobronchial Ultrasound Biopsy Hospitals , by Region USD Million (2018-2023)
  • Table 14. Endobronchial Ultrasound Biopsy Cancer Specialty Clinics , by Region USD Million (2018-2023)
  • Table 15. Endobronchial Ultrasound Biopsy Ambulatory Surgical Centers , by Region USD Million (2018-2023)
  • Table 16. Endobronchial Ultrasound Biopsy Diagnostic Centers , by Region USD Million (2018-2023)
  • Table 17. South America Endobronchial Ultrasound Biopsy, by Country USD Million (2018-2023)
  • Table 18. South America Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 19. South America Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 20. South America Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 21. Brazil Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 22. Brazil Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 23. Brazil Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 24. Argentina Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 25. Argentina Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 26. Argentina Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 27. Rest of South America Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 28. Rest of South America Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 29. Rest of South America Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 30. Asia Pacific Endobronchial Ultrasound Biopsy, by Country USD Million (2018-2023)
  • Table 31. Asia Pacific Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 32. Asia Pacific Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 33. Asia Pacific Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 34. China Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 35. China Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 36. China Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 37. Japan Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 38. Japan Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 39. Japan Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 40. India Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 41. India Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 42. India Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 43. South Korea Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 44. South Korea Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 45. South Korea Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 46. Taiwan Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 47. Taiwan Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 48. Taiwan Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 49. Australia Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 50. Australia Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 51. Australia Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 52. Rest of Asia-Pacific Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 53. Rest of Asia-Pacific Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 54. Rest of Asia-Pacific Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 55. Europe Endobronchial Ultrasound Biopsy, by Country USD Million (2018-2023)
  • Table 56. Europe Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 57. Europe Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 58. Europe Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 59. Germany Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 60. Germany Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 61. Germany Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 62. France Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 63. France Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 64. France Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 65. Italy Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 66. Italy Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 67. Italy Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 68. United Kingdom Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 69. United Kingdom Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 70. United Kingdom Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 71. Netherlands Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 72. Netherlands Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 73. Netherlands Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 74. Rest of Europe Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 75. Rest of Europe Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 76. Rest of Europe Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 77. MEA Endobronchial Ultrasound Biopsy, by Country USD Million (2018-2023)
  • Table 78. MEA Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 79. MEA Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 80. MEA Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 81. Middle East Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 82. Middle East Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 83. Middle East Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 84. Africa Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 85. Africa Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 86. Africa Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 87. North America Endobronchial Ultrasound Biopsy, by Country USD Million (2018-2023)
  • Table 88. North America Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 89. North America Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 90. North America Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 91. United States Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 92. United States Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 93. United States Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 94. Canada Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 95. Canada Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 96. Canada Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 97. Mexico Endobronchial Ultrasound Biopsy, by Type USD Million (2018-2023)
  • Table 98. Mexico Endobronchial Ultrasound Biopsy, by Application USD Million (2018-2023)
  • Table 99. Mexico Endobronchial Ultrasound Biopsy, by End User USD Million (2018-2023)
  • Table 100. Endobronchial Ultrasound Biopsy: by Type(USD/Units)
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Endobronchial Ultrasound Biopsy: by Type(USD Million)
  • Table 113. Endobronchial Ultrasound Biopsy Biopsy Forceps , by Region USD Million (2025-2030)
  • Table 114. Endobronchial Ultrasound Biopsy Cytology Brushes , by Region USD Million (2025-2030)
  • Table 115. Endobronchial Ultrasound Biopsy Biopsy Needles , by Region USD Million (2025-2030)
  • Table 116. Endobronchial Ultrasound Biopsy Transbronchial Aspiration Needles , by Region USD Million (2025-2030)
  • Table 117. Endobronchial Ultrasound Biopsy Spray Catheters , by Region USD Million (2025-2030)
  • Table 118. Endobronchial Ultrasound Biopsy Others , by Region USD Million (2025-2030)
  • Table 119. Endobronchial Ultrasound Biopsy: by Application(USD Million)
  • Table 120. Endobronchial Ultrasound Biopsy Infection Diagnosis , by Region USD Million (2025-2030)
  • Table 121. Endobronchial Ultrasound Biopsy Cancer Diagnosis , by Region USD Million (2025-2030)
  • Table 122. Endobronchial Ultrasound Biopsy Others , by Region USD Million (2025-2030)
  • Table 123. Endobronchial Ultrasound Biopsy: by End User(USD Million)
  • Table 124. Endobronchial Ultrasound Biopsy Hospitals , by Region USD Million (2025-2030)
  • Table 125. Endobronchial Ultrasound Biopsy Cancer Specialty Clinics , by Region USD Million (2025-2030)
  • Table 126. Endobronchial Ultrasound Biopsy Ambulatory Surgical Centers , by Region USD Million (2025-2030)
  • Table 127. Endobronchial Ultrasound Biopsy Diagnostic Centers , by Region USD Million (2025-2030)
  • Table 128. South America Endobronchial Ultrasound Biopsy, by Country USD Million (2025-2030)
  • Table 129. South America Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 130. South America Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 131. South America Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 132. Brazil Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 133. Brazil Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 134. Brazil Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 135. Argentina Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 136. Argentina Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 137. Argentina Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 138. Rest of South America Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 139. Rest of South America Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 140. Rest of South America Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 141. Asia Pacific Endobronchial Ultrasound Biopsy, by Country USD Million (2025-2030)
  • Table 142. Asia Pacific Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 143. Asia Pacific Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 144. Asia Pacific Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 145. China Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 146. China Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 147. China Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 148. Japan Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 149. Japan Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 150. Japan Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 151. India Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 152. India Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 153. India Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 154. South Korea Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 155. South Korea Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 156. South Korea Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 157. Taiwan Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 158. Taiwan Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 159. Taiwan Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 160. Australia Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 161. Australia Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 162. Australia Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 163. Rest of Asia-Pacific Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 164. Rest of Asia-Pacific Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 165. Rest of Asia-Pacific Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 166. Europe Endobronchial Ultrasound Biopsy, by Country USD Million (2025-2030)
  • Table 167. Europe Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 168. Europe Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 169. Europe Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 170. Germany Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 171. Germany Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 172. Germany Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 173. France Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 174. France Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 175. France Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 176. Italy Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 177. Italy Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 178. Italy Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 179. United Kingdom Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 180. United Kingdom Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 181. United Kingdom Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 182. Netherlands Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 183. Netherlands Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 184. Netherlands Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 185. Rest of Europe Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 186. Rest of Europe Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 187. Rest of Europe Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 188. MEA Endobronchial Ultrasound Biopsy, by Country USD Million (2025-2030)
  • Table 189. MEA Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 190. MEA Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 191. MEA Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 192. Middle East Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 193. Middle East Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 194. Middle East Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 195. Africa Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 196. Africa Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 197. Africa Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 198. North America Endobronchial Ultrasound Biopsy, by Country USD Million (2025-2030)
  • Table 199. North America Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 200. North America Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 201. North America Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 202. United States Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 203. United States Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 204. United States Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 205. Canada Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 206. Canada Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 207. Canada Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 208. Mexico Endobronchial Ultrasound Biopsy, by Type USD Million (2025-2030)
  • Table 209. Mexico Endobronchial Ultrasound Biopsy, by Application USD Million (2025-2030)
  • Table 210. Mexico Endobronchial Ultrasound Biopsy, by End User USD Million (2025-2030)
  • Table 211. Endobronchial Ultrasound Biopsy: by Type(USD/Units)
  • Table 212. Research Programs/Design for This Report
  • Table 213. Key Data Information from Secondary Sources
  • Table 214. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Endobronchial Ultrasound Biopsy: by Type USD Million (2018-2023)
  • Figure 5. Global Endobronchial Ultrasound Biopsy: by Application USD Million (2018-2023)
  • Figure 6. Global Endobronchial Ultrasound Biopsy: by End User USD Million (2018-2023)
  • Figure 7. South America Endobronchial Ultrasound Biopsy Share (%), by Country
  • Figure 8. Asia Pacific Endobronchial Ultrasound Biopsy Share (%), by Country
  • Figure 9. Europe Endobronchial Ultrasound Biopsy Share (%), by Country
  • Figure 10. MEA Endobronchial Ultrasound Biopsy Share (%), by Country
  • Figure 11. North America Endobronchial Ultrasound Biopsy Share (%), by Country
  • Figure 12. Global Endobronchial Ultrasound Biopsy: by Type USD/Units (2018-2023)
  • Figure 13. Global Endobronchial Ultrasound Biopsy share by Players 2023 (%)
  • Figure 14. Global Endobronchial Ultrasound Biopsy share by Players (Top 3) 2023(%)
  • Figure 15. Global Endobronchial Ultrasound Biopsy share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Olympus Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 18. Olympus Corporation (Japan) Revenue: by Geography 2023
  • Figure 19. Medtronic (Ireland) Revenue, Net Income and Gross profit
  • Figure 20. Medtronic (Ireland) Revenue: by Geography 2023
  • Figure 21. Cook Medical (United States) Revenue, Net Income and Gross profit
  • Figure 22. Cook Medical (United States) Revenue: by Geography 2023
  • Figure 23. CONMED Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 24. CONMED Corporation (United States) Revenue: by Geography 2023
  • Figure 25. Medi-Globe Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 26. Medi-Globe Corporation (United States) Revenue: by Geography 2023
  • Figure 27. Veran Medical Technologies (United States) Revenue, Net Income and Gross profit
  • Figure 28. Veran Medical Technologies (United States) Revenue: by Geography 2023
  • Figure 29. Boston Scientific Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Boston Scientific Corporation (United States) Revenue: by Geography 2023
  • Figure 31. ACE Medical Devices Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 32. ACE Medical Devices Pvt. Ltd. (India) Revenue: by Geography 2023
  • Figure 33. CLINODEVICE (Turkey) Revenue, Net Income and Gross profit
  • Figure 34. CLINODEVICE (Turkey) Revenue: by Geography 2023
  • Figure 35. ENDO-FLEX GmbH (Germany) Revenue, Net Income and Gross profit
  • Figure 36. ENDO-FLEX GmbH (Germany) Revenue: by Geography 2023
  • Figure 37. Micro-Tech Endoscopy (United States) Revenue, Net Income and Gross profit
  • Figure 38. Micro-Tech Endoscopy (United States) Revenue: by Geography 2023
  • Figure 39. Global Endobronchial Ultrasound Biopsy: by Type USD Million (2025-2030)
  • Figure 40. Global Endobronchial Ultrasound Biopsy: by Application USD Million (2025-2030)
  • Figure 41. Global Endobronchial Ultrasound Biopsy: by End User USD Million (2025-2030)
  • Figure 42. South America Endobronchial Ultrasound Biopsy Share (%), by Country
  • Figure 43. Asia Pacific Endobronchial Ultrasound Biopsy Share (%), by Country
  • Figure 44. Europe Endobronchial Ultrasound Biopsy Share (%), by Country
  • Figure 45. MEA Endobronchial Ultrasound Biopsy Share (%), by Country
  • Figure 46. North America Endobronchial Ultrasound Biopsy Share (%), by Country
  • Figure 47. Global Endobronchial Ultrasound Biopsy: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Olympus Corporation (Japan)
  • Medtronic (Ireland)
  • Cook Medical (United States)
  • CONMED Corporation (United States)
  • Medi-Globe Corporation (United States)
  • Veran Medical Technologies (United States)
  • Boston Scientific Corporation (United States)
  • ACE Medical Devices Pvt. Ltd. (India)
  • CLINODEVICE (Turkey)
  • ENDO-FLEX GmbH (Germany)
  • Micro-Tech Endoscopy (United States)
Select User Access Type

Key Highlights of Report


Jan 2024 231 Pages 74 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Endobronchial Ultrasound Biopsy Quantitative research analysis
Global Endobronchial Ultrasound Biopsy Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Olympus Corporation (Japan), Medtronic (Ireland), Cook Medical (United States), CONMED Corporation (United States), Medi-Globe Corporation (United States), Veran Medical Technologies (United States), Boston Scientific Corporation (United States), ACE Medical Devices Pvt. Ltd. (India), CLINODEVICE (Turkey), ENDO-FLEX GmbH (Germany) and Micro-Tech Endoscopy (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"The Rapidly Growing Fields of Gastroenterology and Pulmonology " is seen as one of major influencing trends for Endobronchial Ultrasound Biopsy Market during projected period 2023-2030.
The Endobronchial Ultrasound Biopsy market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Endobronchial Ultrasound Biopsy Report?

Have a Query? Click Here

Other Related Reports

Chamomile Oil Comprehensive Study by Type (High-Quality, Middle-Quality, Low-Quality), Application (Essential Oils, Other), Nature (Organic Chamomile Essential Oil, Conventional Chamomile Essential O...
$ 3450
Drugs of Abuse Testing Comprehensive Study by Type (Analyzers (Immunoassay Analyzers, Chromatographic Devices, Breath Analyzers), Rapid Testing Devices (Urine Testing Devices, Oral Fluid Testing Devi...
$ 3750
Sterilization Monitoring Comprehensive Study by Type (Biological Indicators, Chemical Indicators), Application (Hospitals, Pharmaceutical, Biotechnology, and Medical Device Companies, Research and Ac...
$ 3800
Retail Clinics Comprehensive Study by Type (Hospital-owned Retail Clinics, Retail-owned Retail Clinics), Application (Clinical Chemistry & Immunoassay, Point of Care Diagnostics, Others), Distributio...
$ 3500
Dental Drug Comprehensive Study by Type (Injectable, Oral, Spray), Application (Drug stores, Retail pharmacies, Hospital pharmacies, Online stores) Players and Region - Global Market Outlook to 2026
$ 3500
Prostate Cancer Diagnostics Comprehensive Study by Type (Tumor Biomarker Tests, Imaging, Biopsy, Other), Treatment (Surveillance, Localized Therapy, Systemic Therapy, Others), Test Type (Preliminary ...
$ 3750